Frasch et al., 1988 - Google Patents
Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccineFrasch et al., 1988
- Document ID
- 6990449996366226957
- Author
- Frasch C
- Zahradnik J
- Wang L
- Mocca L
- Tsai C
- Publication year
- Publication venue
- Journal of Infectious Diseases
External Links
Snippet
A group B Neisseria meningitidis serotype protein vaccine was studied clinically in adults. The vaccine comprised lipopolysaccharide-depleted outer membrane vesicles from a serotype 2b strain, 3006-M2, noncovalently complexed with group B meningococcal …
- 229960005486 vaccines 0 title abstract description 125
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boslego et al. | Efficacy, safety, and immunogenicity of a meningococcal group B (15: P1. 3) outer membrane protein vaccine in Iquique, Chile | |
| Frasch et al. | Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine | |
| US4601903A (en) | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease | |
| Gold et al. | Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. | |
| Robbins et al. | Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi | |
| AU2022203720B2 (en) | Neisseria meningitidis compositions and methods thereof | |
| Granoff et al. | Meningococcal vaccines | |
| Powers et al. | Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults | |
| Goldschneider et al. | Human immunity to the meningococcus: II. Development of natural immunity | |
| US7491517B2 (en) | Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135 | |
| Bruyn et al. | Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations | |
| Smith et al. | Oral immunization of humans with Streptococcus sobrinus glucosyltransferase | |
| Mandrell et al. | Complement-mediated bactericidal activity of human antibodies to poly α2→ 8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B | |
| Yogev et al. | Meningococcal disease: the advances and challenges of meningococcal disease prevention | |
| Glode et al. | Comparative Immunogenicity of Vaccines Prepared from Capsular Polysaccharides of Group C Neisseria meningitidis O. Acetyl. Positive and O. Acetyl. Negative Variants and Escherichia coli K92 in Adult Volunteers | |
| Henderson et al. | Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. | |
| TW202011985A (en) | Capsular saccharide of streptococcus pneumoniae and the immunogenic conjugates thereof | |
| Reher et al. | A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab | |
| WO1992019970A1 (en) | Methods to detect and treat diseases caused by bacterial allergens | |
| Hedlund et al. | Recurrence of pneumonia in relation to the antibody response after pneumococcal vaccination in middle-aged and elderly adults | |
| Söderström et al. | Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera | |
| Vodopija et al. | Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide | |
| CN101443454A (en) | Polysaccharide-protein latticeing substance and vaccine derivatized from polyvalent meningitis cocci | |
| Fox et al. | Primary immunization of infants and children with group A streptococcal M protein | |
| Fischer et al. | Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease |